email article
In a surprise move, FDA declined to approve lipid lowering drug inclisiran over inability to inspect the manufacturing facility. (
Endpoints News)
Life expectancy rose slightly in 2019, with heart disease still the top cause of mortality, but COVID-19 is likely to change all of that for 2020. (
AP,
CDC)
A cardiac MRI study of 59 athletes with mild or asymptomatic COVID-19 turned up myocarditis in two (3%), one of whom subsequently developed symptomatic low ejection fraction. Focal late gadolinium enhancement was equally common in them as in control athletes (22% vs 24%). (
Circulation)
Fully 95% of cardiac cath lab nurses and technologists reported poorer morale and increased mental distress, including depression in 36%, due to the pandemic, according to a national survey. (